<DOC>
	<DOCNO>NCT00003387</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether give chemotherapy combine chemotherapy radiation therapy effective combine chemotherapy radiation therapy alone treat patient non-small cell lung cancer . PURPOSE : Randomized phase III trial compare effectiveness carboplatin paclitaxel follow radiation therapy chemotherapy radiation therapy chemotherapy alone treat patient stage III non-small cell lung cancer remove surgery .</brief_summary>
	<brief_title>Carboplatin , Paclitaxel , Radiation Therapy Treating Patients With Stage III Non-small Cell Lung Cancer That Can Be Removed During Surgery</brief_title>
	<detailed_description>OBJECTIVES : I . Compare effect concurrent chemoradiotherapy utilize carboplatin paclitaxel without prior induction chemotherapy overall response rate , disease-free survival , overall survival patient unresectable stage III non-small cell lung cancer . II . Compare effect treatments locoregional v distant failure patient . III . Compare toxicity treatment patient . OUTLINE : This randomize study . Patients stratify measurable v evaluable disease . Patients randomize 1 2 treatment arm : Arm I ( immediate concurrent chemoradiotherapy ) : Patients receive IV paclitaxel 1 hour follow IV carboplatin 30 minute day 1 , radiation therapy chest 5 time week begin day 1 . Treatment repeat weekly total 7 course . Arm II ( induction chemotherapy follow delayed concurrent chemoradiotherapy ) : Patients receive IV paclitaxel 3 hour follow IV carboplatin 30 minute ; treatment repeat every 3 week 2 course . Patients receive 7 course concurrent chemoradiotherapy Arm I . Total treatment time 13 week . Patients follow every 2 month 2 year , every 4 month next 2 year , annually thereafter . PROJECTED ACCRUAL : A total 360 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung cancer , include : Squamous cell carcinoma Adenocarcinoma ( include bronchoalveolar cell ) Large cell anaplastic carcinoma ( include giant clear cell carcinoma ) Inoperable unresectable stage IIIA IIIB disease follow stage grouping : T1 N2 M0 T2 N2 M0 T3 N2 M0 T4 N02 M0 eligible stag base closeness carina invasion mediastinum chest wall Patients contralateral mediastinal disease ( N3 ) tumor adjacent invade vertebral body eligible gross disease encompass study radiation boost field Patients transudate , cytologically negative , nonbloody pleural effusion eligible tumor encompass within reasonable field radiotherapy Measurable evaluable disease PATIENT CHARACTERISTICS : Age : 18 Performance status : CALBG 01 Life expectancy : Not specify Hematopoietic : Platelet count least 100,000/mm3 Absolute granulocyte count least 1,500/mm3 Hepatic : Bilirubin le 1.5 mg/dL AST le 2 time upper limit normal Renal : Creatinine clearance least 20 mL/min Other : Not pregnant nursing Effective contraception require fertile patient No active second malignancy except nonmelanomatous skin cancer PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy No concurrent chemotherapy Endocrine therapy : No concurrent hormones except steroid administer adrenal failure septic shock , hormone administer nondiseaserelated condition ( e.g. , insulin diabetes ) Glucocorticosteroids permit antiemetic Radiotherapy : No prior radiotherapy Surgery : At least 2 week since exploratory thoracotomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage III non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
</DOC>